TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change from baseline in bone mineral density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of secondary catheter failures
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With Rhinovirus PCR-Positive Colds
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With Asthma Exacerbations Together With Rhinovirus-Positive PCR
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Ventricular Arrhythmia Associated Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Infant outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in total registered sickness absenteeism
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Number of Subjects With PSMA-positive Dominant PC Lesion(s) Greater Than 5mm Identified by 89Zr-df-IAB2M PET/CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Subjects With PSMA-positive Dominant PC Lesion(s) Greater Than 5mm Identified by 68Ga-PSMA-HBED-CC PET/CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in polysomnographic scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in movement efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change in Plasma Concentration of Inflammatory Biomarkers IL-6 and PBMC TNF-α
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean Change in Depression Severity Score (IDS-C30)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percent Change in IDS-C Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Real-World Event-Free Survival (rwEFS)
Endpoint domain: Mortality/survival
Primary endpoint: Real-World Relapse Free Survival (rwRFS)
Endpoint domain: Mortality/survival
Primary endpoint: Real-World Overall Survival (rwOS)
Endpoint domain: Mortality/survival
Primary endpoint: Frequency of Clinically Significant Clinical Events of Interest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of Clinically Significant Clinical Events of Interest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of Clinically Significant Clinical Events of Interest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain relief and pain intensity difference scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alteration of the DLCO
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Pedicle screw loosening rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of subjects with clinical benefit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidence of invasive mold infection
Endpoint domain: Adverse events/effects
Primary endpoint: Serum levels of anti-beta1-adrenergic receptor autoantibody bound JNJ-54452840
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum levels of free JNJ-54452840
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Beta1-adrenergic receptor activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of plasma pharmacokinetic (PK) parameters of GSK2190915
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weekday Sun Exposure - NHW
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sunburns - NHW
Endpoint domain: Adverse events/effects
Primary endpoint: Wearing Sunscreen - NHW
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incontinence Visual Analogue Scale (I-VAS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hearing Threshold level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speech test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HISQUI (Hearing Implant Sound Quality Index)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Delayed Nausea
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of atypical endometrial hyperplasia or endometrial cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of good responders (G1 or G2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HBV-DNA < 300 Copies/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FFQ estimated carotenoid intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of carotenoids in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CCAT ability to estimate carotenoid intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to reach 1.5 MAC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Amount of goal achievement l: CSR-R
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Amount of goal achievement II: BAVESTA
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Amount of goal achievement III: VAS
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion of infants with procedural pain assessed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of infants with procedural pain management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of painful procedures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effects of Drug
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Engagement in Recovery Services
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Change in Substance Use Frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient preference for inhaler devices
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in systemic oxidative stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Genomic DNA oxidative damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Worsening liver function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rates of dysfunctional syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in inflammation-related markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: improvement of nasal breathing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lipid parameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Empiric Antibiotic Duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Empiric Antibiotics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of severe hypoglycemia or documented hypoglycemic events
Endpoint domain: Adverse events/effects
Primary endpoint: Immunologic (CD8+ T cell and T regulatory cell (Treg) infiltration)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: AUCinf of tasocitinib (CP-690,550)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of tasocitinib (CP-690,550)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FFR-stimulus-f0 Correlation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Recovery time after THA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Osseous Healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Detection Speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brain activation during an emotion regulation task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Brain activation during the Stroop task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Adherence to MPOWER program homework assignments
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Satisfaction with the MPOWER program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Wender-Reimherr Adult Attention Deficit Disorder Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Genotypes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relationship between genotypes and concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive Test Performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Percentage of patients receiving chemotherapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Tenofovir Diphosphate Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nightmare Effects Survey
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Posttraumatic Stress Disorder Checklist- Stressor Specific Version
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Modulation of HIF-1Alpha protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total score of subjective symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Delayed primary fascial closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Area Under the Concentration-time Curve From 0 to the Time of the Last Quantifiable Concentration (AUC0-tz)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-time Curve From 0 Extrapolated to Infinity (AUC0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Patients with adverse events, serious adverse events and death
Endpoint domain: Adverse events/effects
Primary endpoint: Area under the effect curve (AUC0-4h) over the 4-hour post-dose period to measure glucose response following a standard mixed meal test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Increased outflow facility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neuropsychiatric Inventory with Caregiver Distress (NPI-D) Sleep Behavior Subscale
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: The Epworth Sleepiness Scale
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Sleep Disorders Questionnaire (short form)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Steady-state Area Under the Plasma Concentration Versus Time Curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Steady-state Maximum Observed Plasma Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Steady-state Minimum Observed Plasma Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Patients Producing Anti-FSH Antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Median frequency slope of the lumbar muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Maximal isometric force of the lumbar muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Bronchiolitis Severity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Immune alterations via T-cell subtypes and function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cognitive outcome after stroke
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: % of Mean Difference in T Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean assay value using new VP1u ELISA and neutralization assays
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic results (normal versus abnormal)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Muscle strength (Hand-grip)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle strength (Leg extension)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duplex-sonographic recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measures of adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Area Under the Concentration-Time Curve from time 0 to the Time of the Last Measurable non-Below Quantification Limit Concentration (AUC [0-last])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Body Weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Deviation of guide pin placement position
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Deviation of screw placement position
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Intraoperative Complications
Endpoint domain: Adverse events/effects
Primary endpoint: Subacute Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: HOFFMAN score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Polysomnographic efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients who reach target blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of Participant Login
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Improvement in management of immune related grade 3 and 4 diarrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Improvement in management of persistent grade 2 diarrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence rate of Adverse Events (AE)/Adverse Drug Reactions (ADR)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Serious Adverse Events (SAE)/Adverse Drug Reactions (ADR)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Unexpected Adverse Events (AE)/Adverse Drug Reactions (ADR)
Endpoint domain: Adverse events/effects
Primary endpoint: Acute rejection (AR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: performance of the ATI Neurostimulation System
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the Length of Stay in the Hospital
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Improvement of at least 4 points on ADAS-COG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Gross motor function measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Closure of external openings of perianal fistula
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trough Seated Diastolic Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: changes in labour-associated maternal and fetal hormone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change from Transepidermal Water Loss (TEWL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Surgical Margin Negative Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Recruitment rate when embedded within a course
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Recruitment rate when not embedded within a course
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Recruitment time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Thoracic kyphosis and lumbar lordosis angle assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Temporomandibular range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measuring the cervical joint range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Craniovertebral angle measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tragus-to-wall distance measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scoliosis angle assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infant Intake During the Observed Feeding (mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal Sensitivity to Infant Cues
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Feasibility of implementing the WWE intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Polysomnography indexes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Outcome after implantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non-inferiority of PEF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Non-inferiority of FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Non-inferiority of FVC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Proportion of Patients Who Maintain Plasma HIV Viral Load < 400 Copies/ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Positive Antibody Responses to Pneumococcal Vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Risk of unplanned pregnancy
Endpoint domain: Mortality/survival
Primary endpoint: Centre of pressure displacement in standing position
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ability of AED to recognise induced VF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Bonding quality
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in work status
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Degree of fatty liver
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: HCV Viral Kinetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal Body Weight Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Uptake of 18F-FCWAY in brain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: PTSD Checklist - 5
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Connors Davidson Resilience Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Patients With Adverse Effects
Endpoint domain: Adverse events/effects
Primary endpoint: Post Intensive Care Syndrome (PICS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Pain tolerance threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS score for pain at pressure step 29 mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hand Tremor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Metabolic Syndrome Extent
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Participants Discontinuing Treatment Due to AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Overall Response Rate (ORR) Per Central Radiology Review Using RECIST Version 1.1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Physiological course of PSP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Proportion of splayed region with no contraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of reinfusion of target cell dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of reinfusion of minimum accepted cell dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nonfatal myocardial infarction or coronary death
Endpoint domain: Mortality/survival
Primary endpoint: Length of Labor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Mean number of treatments per group
Endpoint domain: Resource use
Endpoint subdomain: Other resource use